Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

1.6K
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
1.6K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Molecular insights into the anti-COVID-19 activity of reduced (quinol) and oxidized (quinone) forms of coenzyme Q10.

Naunyn-Schmiedeberg's archives of pharmacology·2026
Same author

TDCPP induces ferroptosis in THP-1 macrophages through mitochondrial regulation of Fe<sup>2 +</sup> homeostasis.

Ecotoxicology and environmental safety·2026
Same author

Autophagy in thyroid cancer: Immune suppression and drug resistance.

Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy·2026
Same author

Retraction notice to "Gene regulation by antisense transcription: A focus on neurological and cancer diseases" [Biomedicine & Pharmacotherapy 145 (2022) 112265].

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same author

DP103 as a critical modulator of Wnt signaling and cancer stemness: implications for precision treatment in triple negative breast cancer.

Cell death & disease·2026
Same author

Genistein and the immune system: experimental evidence, key challenges, and future perspectives.

Biochemical pharmacology·2026

相关实验视频

Updated: Sep 10, 2025

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells
10:01

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Published on: August 2, 2022

7.0K

释放治疗潜力:探索脑癌治疗中的核受体

Sujitha Jayaprakash1, Hiu Yan Lam2,3, Ravichandran Vishwa1

  • 1Cancer Biology Laboratory, Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati, Guwahati 781039, Assam, India.

Chinese medical journal
|August 25, 2025
PubMed
概括
此摘要是机器生成的。

脑癌是一种致命的疾病, 核受体 (NRs) 涉及到脑瘤的生长和对治疗的抵抗,提供潜在的新治疗点.

关键词:
抗激素剂敌对者生物标志物大脑癌症核受体治疗方法

更多相关视频

Intracarotid Cancer Cell Injection to Produce Mouse Models of Brain Metastasis
07:43

Intracarotid Cancer Cell Injection to Produce Mouse Models of Brain Metastasis

Published on: February 8, 2017

27.1K
Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells
05:02

Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells

Published on: February 4, 2021

3.4K

相关实验视频

Last Updated: Sep 10, 2025

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells
10:01

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Published on: August 2, 2022

7.0K
Intracarotid Cancer Cell Injection to Produce Mouse Models of Brain Metastasis
07:43

Intracarotid Cancer Cell Injection to Produce Mouse Models of Brain Metastasis

Published on: February 8, 2017

27.1K
Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells
05:02

Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells

Published on: February 4, 2021

3.4K

科学领域:

  • 癌症学
  • 分子生物学
  • 内分泌学

背景情况:

  • 脑癌是全球癌症死亡的主要原因,
  • 核受体是细胞过程的关键调节者, 它们的失调与癌症越来越相关.
  • 特定的NR异常促进了脑瘤的侵袭性特征,包括生存,增殖和治疗耐药性.

研究的目的:

  • 审查关键核受体 (NR) 在脑癌发育和进展中的作用.
  • 在恶性脑瘤中检查NR的预后意义.
  • 评估针对脑癌的治疗潜力.

主要方法:

  • 对脑癌中核受体的研究进行文献综述.
  • 分析不同类型的大脑瘤中的NR表达和功能.
  • 对NR向治疗的临床前和临床数据的评估.

主要成果:

  • 异常的NR信号有助于大脑瘤的标志性癌症表型.
  • 一些NR的表达变化与患者的预后有关.
  • 在临床前模型中,针对特定的NR用激动剂或抗剂显示出治疗前景.

结论:

  • 核受体在脑癌的发病过程中起着重要作用.
  • 对于大脑恶性瘤来说,NRs是有前途的预后生物标志物和治疗点.
  • 对NR向治疗的进一步研究可能会为脑癌患者改善治疗策略.